375 related articles for article (PubMed ID: 8491041)
1. Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats.
Toney GM; Porter JP
Brain Res Dev Brain Res; 1993 Feb; 71(2):193-9. PubMed ID: 8491041
[TBL] [Abstract][Full Text] [Related]
2. Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats.
Toney GM; Porter JP
Neuropharmacology; 1993 Jun; 32(6):581-9. PubMed ID: 8336821
[TBL] [Abstract][Full Text] [Related]
3. Functional role of brain AT1 and AT2 receptors in the central angiotensin II pressor response.
Toney GM; Porter JP
Brain Res; 1993 Feb; 603(1):57-63. PubMed ID: 8453478
[TBL] [Abstract][Full Text] [Related]
4. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.
Hogarty DC; Speakman EA; Puig V; Phillips MI
Brain Res; 1992 Jul; 586(2):289-94. PubMed ID: 1521162
[TBL] [Abstract][Full Text] [Related]
5. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
Morita O; Kushida H; Kunihara M
J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
[TBL] [Abstract][Full Text] [Related]
6. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
7. Role of AT2 receptors in angiotensin II-stimulated contraction of small mesenteric arteries in young SHR.
Touyz RM; Endemann D; He G; Li JS; Schiffrin EL
Hypertension; 1999 Jan; 33(1 Pt 2):366-72. PubMed ID: 9931131
[TBL] [Abstract][Full Text] [Related]
8. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
9. The neurogenic origin of hypertension in SHR may be mediated by angiotensin II through a receptor different from AT1 and AT2.
Paré MC; Maltais S; Escher E
Regul Pept; 1993 Aug; 47(1):81-6. PubMed ID: 8210522
[TBL] [Abstract][Full Text] [Related]
10. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
Gorbea-Oppliger VJ; Fink GD
J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062
[TBL] [Abstract][Full Text] [Related]
11. Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain ANG II.
Huang BS; Leenen FH
Am J Physiol; 1996 Jan; 270(1 Pt 2):H275-80. PubMed ID: 8769762
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.
Lark LA; Wappel SM; Weyhenmeyer JA
J Pharmacol Exp Ther; 1995 Aug; 274(2):745-51. PubMed ID: 7636738
[TBL] [Abstract][Full Text] [Related]
13. Involvement of angiotensin receptor subtypes in osmotically induced release of vasopressin.
Hogarty DC; Tran DN; Phillips MI
Brain Res; 1994 Feb; 637(1-2):126-32. PubMed ID: 8180789
[TBL] [Abstract][Full Text] [Related]
14. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T
Eur J Pharmacol; 1999 Feb; 367(2-3):255-65. PubMed ID: 10079000
[TBL] [Abstract][Full Text] [Related]
15. Sympatho-inhibitory actions of irbesartan in pithed spontaneously hypertensive and Wistar-Kyoto rats.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 2003 Feb; 17(1):83-91. PubMed ID: 12588634
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist.
Höhle S; Spitznagel H; Rascher W; Culman J; Unger T
Eur J Pharmacol; 1995 Mar; 275(3):277-82. PubMed ID: 7768295
[TBL] [Abstract][Full Text] [Related]
17. Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats.
Kawano Y; Yoshida K; Matsuoka H; Omae T
Am J Hypertens; 1994 Jun; 7(6):536-42. PubMed ID: 7917152
[TBL] [Abstract][Full Text] [Related]
18. Central ANG II-receptor antagonists impair cardiovascular and vasopressin response to hemorrhage in rats.
Lee WJ; Yang EK; Ahn DK; Park YY; Park JS; Kim HJ
Am J Physiol; 1995 Jun; 268(6 Pt 2):R1500-6. PubMed ID: 7611527
[TBL] [Abstract][Full Text] [Related]
19. Losartan, nonpeptide angiotensin II-type 1 (AT1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla.
Averill DB; Tsuchihashi T; Khosla MC; Ferrario CM
Brain Res; 1994 Dec; 665(2):245-52. PubMed ID: 7895060
[TBL] [Abstract][Full Text] [Related]
20. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
Gohlke P; Pees C; Unger T
Hypertension; 1998 Jan; 31(1 Pt 2):349-55. PubMed ID: 9453327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]